Antiganglioside antibodies in peripheral neuropathies;Anticuerpos antigangliósido en neuropatías periféricas

Neurologia

Volumn 16, Issue 7, 2001, Pages 289-292

  Pardo, J ^a  

^a University Hospital of Santiago de Compostela   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE ANTIBODY;

EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; GUILLAIN BARRE SYNDROME; INFLAMMATION; MOTOR NEUROPATHY; NERVE FIBER MEMBRANE; NEUROLOGY; PERIPHERAL NEUROPATHY; POLYRADICULONEUROPATHY;

ANTIBODIES, NEOPLASM; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; GANGLIOSIDES; HUMANS; PARANEOPLASTIC POLYNEUROPATHY; PARAPROTEINEMIAS; PERIPHERAL NERVOUS SYSTEM DISEASES; POLYNEUROPATHIES; POLYRADICULONEUROPATHY; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING;

EID: 17344380518     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (39)

1. Myelin associated glycoprotein is the antigen for a monoclonal IgM in polyneuropathy
2. Antisulfatide antibodies in neuropathy: Clinical and electrophysiologic correlates
3. Autoantibodies associated with peripheral neuropathy
4. Anticuerpos antigangliósido: Cuándo, cuál y para qué
5. Immunology of gangliosides
6. Measurement and significance of antibodies against GM1 ganglioside. Report of a workshop
7. Interlaboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies
8. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome
9. Clinical correlate and fine specificity of anti-GQ1b antibodies in peripheral neuropathy
10. Miller Fisher anti-GQ1b antibodies: Alatrotoxin-like effects on motor end plates
11. Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome
12. Anti-GM1 antibodies in patients with Guillain-Barré syndrome
13. Anti-GM1 antibodies can block neuronal voltage-gated sodium channels
14. The pattern of anti-ganglioside antibody reactivities producing myelinated nerve conduction block in vitro
15. Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro
16. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome
17. IgG antiganglioside antibodies in Guillain-Barré syndrome with bulbar palsy
18. Prominent sensory ataxia in Guillain-Barré syndrome associated with IgG anti-GD1b antibody
19. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure
20. Molecular mimicy between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome
21. Haemophilus influenzae has a GM1 ganglioside-like structure and elicits Guillain-Barré syndrome
22. Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barré syndrome
23. Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy
24. Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy
25. Antibody panels in idiopathic polyneuropathy and motor neuron disease
26. Chronic motor neuropathies: Diagnosis, therapy and pathogenesis
27. Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates
28. Marginally improved detection of GM1 antibodies by covalink ELISA in multifocal motor neuropathy
29. To test or not to test? That is the question
30. Multifocal motor neuropathy
31. Détection des autoanticorps antigangliosides par immunodot-blot: Intérêt dans le diagnostic des neuropathies périphériques auto-immunitaires
32. Monoclonal IgM in a patient with paraproteinemic polyneuropathy binds to ganglioside containing disialosyl groups
33. A somatically mutated human anti-ganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy gene chain VI-18
34. Experimental sensory neuropathy induced by sensitisation with ganglioside GD1b
35. Gangliosides of human melanoma
36. Chronic inflammatory demyelinating polyneuropathy associated with malignant melanoma
37. Chronic inflammatory demyelinating polyneuropathy associated with carcinoma
38. Demyelinating neuropathy triggered by melanoma immunotherapy
39. Clinical presentation and outcome of Guillain-Barré and related syndrome in relation to anti-ganglioside antibodies